Stockscreener 앱 받기
7.67
0.13%
0.02
Evolus Inc 주식(EOLS)의 최신 뉴스
Is a relief rally coming for Evolus Inc. holdersTrade Entry Summary & Daily Growth Stock Investment Tips - Newser
Price action breakdown for Evolus Inc.Volume Spike & Weekly Watchlist for Hot Stocks - Newser
What indicators show strength in Evolus Inc.July 2025 Recap & Advanced Technical Signal Analysis - Newser
How to interpret RSI for Evolus Inc. stockEarnings Growth Report & Real-Time Chart Breakout Alerts - Newser
Evolus CMO Tomoko Yamagishi-Dressler Sells 5,722 Shares at $7.51/Share on 2025-08-22 - AInvest
Using Bollinger Bands to evaluate Evolus Inc.2025 Market Outlook & Community Verified Trade Alerts - Newser
Short Interest Drops in Evolus Inc. After Rally getLinesFromResByArray error: size == 0 - kangso.co.kr
Visual analytics tools that track Evolus Inc. performance2025 Top Decliners & Free Risk Controlled Daily Trade Plans - Newser
Applying big data sentiment scoring on Evolus Inc.2025 Market Sentiment & Safe Entry Zone Tips - Newser
Evolus Submits Evolysse Sculpt for FDA Approval, Expanding HA Dermal Filler Portfolio - newbeauty.com
Evolus announces Evolysse Sculpt trial meets primary endpoint - TipRanks
Evolus announces positive results for Evolysse Sculpt study - MarketScreener
Evolus Announces Positive Data from Pivotal Trial for Evolysse Sculpt Injectable Hyaluronic Acid Gel Product at 2025 Cosmetic Bootcamp - MarketScreener
Has Evolus Inc. found a price floorEntry Point & Fast Moving Market Watchlists - Newser
Multi factor analysis applied to Evolus Inc.July 2025 Patterns & Technical Confirmation Trade Alerts - Newser
Will Evolus Inc. bounce back from current support2025 Macro Impact & Capital Protection Trading Alerts - Newser
Can trapped investors hope for a rebound in Evolus Inc.Weekly Profit Analysis & Real-Time Sentiment Analysis - Newser
What are the risks of holding Evolus Inc.July 2025 Movers & Safe Entry Momentum Stock Tips - theviewers.co.kr
Applying chart zones and confluence areas to Evolus Inc.Trade Performance Summary & High Win Rate Trade Alerts - Newser
Tools to monitor Evolus Inc. recovery probabilityMarket Performance Recap & Capital Efficient Trade Techniques - Newser
Identifying reversal signals in Evolus Inc.July 2025 Sentiment & Community Verified Trade Alerts - Newser
Short Interest Drops in Evolus Inc. After RallyEarnings Overview Report & Verified Chart Pattern Signals - beatles.ru
Evolus Inc. Pullback Analyzed — Is It Time to ExitJuly 2025 Breakouts & Risk Adjusted Buy and Sell Alerts - beatles.ru
Evolus Inc. Volume Confirms Breakout — Analysts BullishJuly 2025 Action & AI Based Buy and Sell Signals - 더경남뉴스
Mizuho reiterates Outperform rating on Evolus stock, maintains $19 target - Investing.com
Mizuho reiterates Outperform rating on Evolus stock, citing valuation - Investing.com
Brady Stewart Bought 59% More Shares In Evolus - simplywall.st
Evolus submits Evolysse premarket approval application to FDA - TipRanks
Latest Company News - Investing.com
Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for Evolysse?? Sculpt Injectable Hyaluronic Acid Gel Product - MarketScreener
Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product - Business Wire
Evolus plunges after Q2 miss, guidance cut; Needham downgrades - MSN
Director’s Bold Move: Major Stock Purchase Signals Confidence in Evolus - TipRanks
Evolus Sees Aesthetic Market Slowing After Q2 Miss - Orange County Business Journal
News impact scoring models applied to Evolus Inc.July 2025 Breakouts & Expert-Curated Trade Recommendations - Newser
Using data filters to optimize entry into Evolus Inc.Weekly Profit Recap & Verified Trade Idea Suggestions - Newser
Is Evolus Inc. stock technically oversold2025 Trading Volume Trends & Low Drawdown Momentum Trade Ideas - thegnnews.com
Is Evolus Inc. Forming a Consolidation BaseJuly 2025 Recap & Trade Opportunity Analysis - metal.it
Live Scanner Shows Breakout on Evolus Inc.Jobs Report & Verified High Yield Trade Plans - 선데이타임즈
Evolus announces commercial launch of Evolysse - MSN
Midday Stock Roundup: ICU Medical Soars, Willdan Group Down - Orange County Business Journal
Is This the Dip to Buy in Evolus Inc.July 2025 Pullbacks & Capital Protection Trade Alerts - metal.it
Resistance Break Could Fuel Evolus Inc. Rally2025 Risk Factors & High Accuracy Swing Entry Alerts - classian.co.kr
Evolus Q2 2025: Unpacking Contradictions in Toxin Demand, Evolysse Launch, and Consumer Sentiment - AInvest
Evolus, Inc. shares rise 11.53% intraday after reporting inducement grants to new employees. - AInvest
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
How liquid is Evolus Inc. stockNext Day Profit Stock Signals - newsyoung.net
Analysts Just Slashed Their Evolus, Inc. (NASDAQ:EOLS) EPS Numbers - simplywall.st
0.79%
0.11%
자본화:
|
볼륨(24시간):